Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (531-540 of 596) with videos related to

Pageof 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C TrialGayathri Anandappa, Andrea Lampis, David Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clustersMargherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2023
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO FoundationSara Lonardi, Cosimo Rasola, Riccardo Lobefaro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2021
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinomaMargherita Correnti, Andrea Cappon, Mirella Pastore, et al.
Gastroenterology|September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in MicePouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2023
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" studyAlessandra A Prete, Paolo Manca, Marco Messina, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinomaMargherita Rimini, Teresa Macarulla, Valentina Burgio, et al.
Nature Communications|December 7, 2018
Induction of immunosuppressive functions and NF-κB by FLIP in monocytesAlessandra Fiore, Stefano Ugel, Francesco De Sanctis, et al.
Targeted Oncology|January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma PatientsMargherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
JCO Precision Oncology|July 30, 2021
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of MetastasesFotios Loupakis, Shruti Sharma, Madiha Derouazi, et al.
Pageof 60

Showing results (531-540 of 596) with videos related to

Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C TrialGayathri Anandappa, Andrea Lampis, David Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2022
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clustersMargherita Rimini, Eleonora Loi, Carles Fabregat-Franco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2023
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO FoundationSara Lonardi, Cosimo Rasola, Riccardo Lobefaro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2021
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinomaMargherita Correnti, Andrea Cappon, Mirella Pastore, et al.
Gastroenterology|September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in MicePouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2023
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" studyAlessandra A Prete, Paolo Manca, Marco Messina, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinomaMargherita Rimini, Teresa Macarulla, Valentina Burgio, et al.
Nature Communications|December 7, 2018
Induction of immunosuppressive functions and NF-κB by FLIP in monocytesAlessandra Fiore, Stefano Ugel, Francesco De Sanctis, et al.
Targeted Oncology|January 23, 2023
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma PatientsMargherita Rimini, Carles Fabregat-Franco, Mara Persano, et al.
JCO Precision Oncology|July 30, 2021
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of MetastasesFotios Loupakis, Shruti Sharma, Madiha Derouazi, et al.
Pageof 60